News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect a high-risk family member are scared.
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
For children, yes, the CDC’s “shared decision-making” guidance preserves the status quo in which Medicaid and U.S.
COVID-19 vaccine recommendations could be changing ... Reuters reported. Other changes include the FDA’s request that both Pfizer and Moderna update their labels with a warning about the ...
Kennedy announced that the CDC is no longer recommending routine COVID-19 vaccinations for pregnant women and healthy ...
The US Centers for Disease Control and Prevention has updated its immunization schedule for children, days after US Health ...
HHS Secretary Robert F. Kennedy Jr. announced that he has unilaterally struck the recommendation that healthy children and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback